Evidence map›Paper›PMID 2835503›Full record

ArticleJournal of virology1988

Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation.

C E Ibanez, J S Lipsick

Abstract read
In one paragraph

Article in Journal of virology, 1988. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Article
  3. Transformation by v-Myb.Oncogene · 1999
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain.Proceedings of the National Academy of Sciences of the United States of America · 1995
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

C E IbanezDepartment of Pathology, University of California, San Diego, La Jolla 92093.
J S Lipsick

Funding

MECHANISM OF TRANSFORMATION BY THE V-MYB ONCOGENESR01CA043592 · NCI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI LIPSICK, JOSEPH STEVEN · 1987 to 2005
$1.5M
NCI NIH HHS CA-43592
6 · The paper itself

Abstract

The v-myb oncogene of avian myeloblastosis virus causes acute myelomonocytic leukemia in vivo and transforms only myeloid cells in vitro. Its product, p48v-myb, is a nuclear protein of unknown function. To determine structure-function relationships for this protein, we constructed a series of deletion mutants of v-myb, expressed them in retroviral vectors, and studied their biochemical and biological properties. We used these mutants to identify two separate domains of p48v-myb which had distinct roles in its accumulation in the cell nucleus. We showed that the viral sequences which normally encode both termini of p48v-myb were dispensible for transformation. In contrast, both copies of the highly conserved v-myb amino-terminal repeat were required for transformation. We also identified a carboxyl-terminal domain of p48v-myb which was required for the growth of v-myb-transformed myeloblasts in soft agar but not for morphological transformation.

Indexed as

Cell Transformation, ViralOncogenesAnimalsAvian Leukosis VirusAvian Myeloblastosis VirusCell CompartmentationCell DivisionCell LineCell NucleusCell Transformation, NeoplasticCoturnixDNA Mutational AnalysisErythroblastsNuclear ProteinsOncogene Proteins, ViralStructure-Activity RelationshipNuclear ProteinsOncogene Proteins, Viral

Identifiers

PMID2835503
PMCPMC253282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.